Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
24.79
-0.04 (-0.14%)
At close: Sep 11, 2026, 4:00 PM EDT
24.60
-0.18 (-0.75%)
After-hours: Sep 11, 2026, 7:30 PM EDT
Maze Therapeutics Market Cap
Maze Therapeutics has a market cap or net worth of $1.37 billion as of September 11, 2026. Its market cap has increased by 94.52% in one year.
Market Cap
1.37B
Enterprise Value
932.02M
1-Year Change
94.52%
Ranking
Category
Stock Price
$24.79
ChartMarket Cap Chart
Since the IPO on January 31, 2025, Maze Therapeutics's market cap has increased from $685.23M to $1.37B, an increase of 99.42%. That is a compound annual growth rate of 53.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 1.37B | -31.45% |
| Dec 31, 2025 | 1.99B | 190.94% |
| Jan 31, 2025 | 685.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LB Pharmaceuticals | 1.44B |
| ArriVent BioPharma | 1.43B |
| Absci | 1.41B |
| Ultragenyx Pharmaceutical | 1.41B |
| Savara | 1.35B |
| Alpha Tau Medical | 1.33B |
| Cullinan Therapeutics | 1.33B |
| Omeros | 1.32B |